| QUOIN PHARMACEUTICALS |
| USA |
| Gesundheit |
| US74907L4095 / A41BEM |
| 2EB0 (Frankfurt) / QNRX (NASDAQ) |
| FRA:2EB0, ETR:2EB0, 2EB0:GR, NASDAQ:QNRX |
| - |
| https://quoinpharma.com/ |
|
Quoin Pharmaceuticals Ltd. - American Depositary Receipt represents shares in a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing therapeutic products for rare and orphan diseases. The company focuses on unme..
>Volltext.. |
| 10.02 Mio. EUR |
| -2.16 Mio. EUR |
| - |
| -15.16 Mio. EUR |
| -14.83 Mio. EUR |
| -205.3 EUR |
| - |
| 2.71 Mio. EUR |
| -13.81 Mio. EUR |
| 2.63 |
| - |
| -63.73% |
| - |
| - |
| - |
| - |
| QUOIN |
| 14.08.26 |
|